While asthma often has genetic roots, Dhaka's harsh environmental conditions have led to an increase in people developing ...

Mepolizumab reduces asthma exacerbations among real-world patients with severe asthma and an eosinophilic phenotype.

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

A team of researchers at University of Michigan and Boston University are tackling neutrophilic asthma, successfully developing one of the first mouse models of the condition.

Censoring research on how to deliver treatments to those most in need isn’t just nonsensical; it puts lives at risk and ...

An asthma attack is a sudden worsening of asthma symptoms caused by inflammation and a narrowing of the airways. This can make breathing difficult and, in severe cases, be life-threatening.Asthma ...

Current asthma treatments don't work in all patients ... The researchers demonstrated that they could treat a mouse model of severe allergic asthma using either a combination of an ICOSL and ...

Current asthma treatments don't work in all patients ... The researchers demonstrated that they could treat a mouse model of severe allergic asthma using either a combination of an ICOSL and ...

This revelation is pushing scientists to reconsider existing treatment strategies and investigate alternative approaches for severe asthma cases that are resistant to conventional therapies.

A double-blind placebo-controlled study using the TNF-α monoclonal antibody infliximab over 6 weeks in 38 patients with moderate-to-severe asthma showed ... in the active-treatment group.